treating her2 exon-20 insertion nsclc with trastuzumab deruxtecan - case based panel discussion
Published 1 year ago • 323 plays • Length 6:18Download video MP4
Download video MP3
Similar videos
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
5:52
case based panel discussion - egfr - exon 20 mutation, treatment, targeted therapy, clinical trials
-
6:15
treatment options for egfr nsclc - case based panel discussion
-
9:15
sunvozertinib & egfr exon 20 insertion nsclc-leading developments & current questions in lung cancer
-
9:41
gracecast- asco lung 2020- enhertu and the potential for treatment of her2 positive nsclc
-
6:50
case based panel discussion 2019 3. egfr uncommon exon 20 mutation - suggested treatments targeted t
-
8:43
asco lung cancer roundtable - nsclc - enhertu and the potential for treatment of her2 positive nsclc
-
5:59
gracecast - are there treatment options for patients with her-2 nsclc
-
4:41
egfr exon-20 mutation - lung cancer video library
-
7:20
treatment of her2 nsclc - 2022 program: targeted therapies forum
-
6:31
gracecast - treatment options for patients with advanced nsclc and a her2- erbb2 mutation
-
3:41
testing methods to discover egfr exon-20 disease - lung cancer video library
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2
-
3:33
emerging treatments and clinical trials for egfr exon-20 - lung cancer video library
-
2:54
her2 mutation positive nsclc
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
11:03
treatment for patients with advanced nsclc - leading developments & current questions in lung cancer
-
11:06
unresectable nsclc - does timing of treatment make a difference in response